Pfizer & BioNTech apply for EU emergency authorization for their Covid Vaccine

COVID Vaccine manufacturing firm Pfizer Inc and BioNTech have applied to the European drugs regulator for conditional authorization of their Covid-19 vaccine, following similar steps in the United States and Britain. The two companies have already applied for the US approval and thus it can be said that launching of Vaccine is nearby.

According to the firm Pfizer and  BioNTech, their vaccine candidate was 95% effective in preventing Cvoid-19, with no major safety concerns, raising the prospect of U.S. and European approval as early as December.

Comments are closed, but trackbacks and pingbacks are open.